Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
ESC Heart Failure|August 26, 2023
Importance of the 'area under the curve' from serial NT-proBNP measurements during treatment with sacubitril/valsartanReza Mohebi, Yuxi Liu, Javed Butler, et al.Journal of the American College of Cardiology|October 13, 2022
Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection FractionReza Mohebi, Yuxi Liu, Ileana L Piña, et al.Journal of Cardiac Failure|September 19, 2022
Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection FractionReza Mohebi, Yuxi Liu, G Michael Felker, et al.JACC. Heart Failure|January 4, 2023
Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/ValsartanReza Mohebi, Yuxi Liu, G Michael Felker, et al.Infectious Disorders Drug Targets|December 31, 2016
In vivo Antibacterial and Wound Healing Activities of Roman Chamomile (Chamaemelum nobile)Hossein Kazemian, Sobhan Ghafourian, Nourkhoda Sadeghifard, et al.Journal of the American College of Cardiology|August 4, 2022
Cardiovascular Disease Projections in the United States Based on the 2020 Census EstimatesReza Mohebi, Chen Chen, Nasrien E Ibrahim, et al.JACC. Heart Failure|February 22, 2024
Early Longitudinal Change in Heart Failure Health Status Following Initiation of CanagliflozinReza Mohebi, Philip G Jones, John A Spertus, et al.Cardiovascular Diabetology|July 12, 2023
Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trialReza Mohebi, Yuxi Liu, Michael K Hansen, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 15, 2023
Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End PointsReza Mohebi, Yuxi Liu, Michael K Hansen, et al.Oral and Maxillofacial Surgery|November 4, 2008
Hydatid cyst of the parotid glandMohsen Darabi, Peyman Varedi, Ali Reza Mohebi, et al.Pageof 7